Experts say that healthy men over the age of 55 may want to consider taking the drug finasteride. A recent survey of 15 studies found that the baldness drug, which goes by the trade names Propecia and Proscar, lowers the level of a hormone that can contribute to the growth of prostate cancer. Some experts warn that the drug can be costly, and that it can cause side effects such as impotence and reduced sexual desire. But experts say it may still be a good treatment option for men who are at...
Read moreDrugs that fall into the category of 5-alpha reductase inhibitors (5 ARIs), such as Avodart (dutasteride) and Proscar (finasteride) have... Read more »
A while back, I was asked if medications for ADHD would prevent someone from being able to give blood. After some research, I can say the... Read more »
In 1992, Merck introduced a revolutionary drug finasteride (Proscar). This drug was the first drug introduced that reduces the size of the... Read more »
The two chief, adverse outcomes from treatment that men diagnosed with prostate cancer most often confront are erectile dysfunction (ED)... Read more »
Men wishing to be fertile or improve their fertility for success in conceiving with a female partner are being warned of an increasingly... Read more »
Researchers say the prostate drug finasteride (Proscar/Propecia) may not be as much of a health risk as previously thought. The drug has been shown... Read more »
Source: ADAM Encyclopedia
Alopecia in men; Baldness - male; Hair loss in men; Androgenetic alopeciaTreatmentTreatment is not necessary if you are comfortable with your... Read more »
Source: ADAM Encyclopedia
Alternative Names Impotence caused by medications; Drug-induced erectile dysfunction Information Various medications and... Read more »
Source: HealthCentral Encyclopedia
Common baldness, sometimes called male- or female-pattern baldness, accounts for 99 percent of hair loss in men and women. Although its exact causes... Read more »
Source: HealthCentral Encyclopedia
Article updated and reviewed by Michael S. Lehrer, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania on April... Read more »